ATE501154T1 - Ein cefdinir-zwischenprodukt - Google Patents

Ein cefdinir-zwischenprodukt

Info

Publication number
ATE501154T1
ATE501154T1 AT03787771T AT03787771T ATE501154T1 AT E501154 T1 ATE501154 T1 AT E501154T1 AT 03787771 T AT03787771 T AT 03787771T AT 03787771 T AT03787771 T AT 03787771T AT E501154 T1 ATE501154 T1 AT E501154T1
Authority
AT
Austria
Prior art keywords
cefdinir
cefdinir intermediate
methylcarbonyloxyimino
aminothiazol
cephem
Prior art date
Application number
AT03787771T
Other languages
English (en)
Inventor
Peter Kremminger
Siegfried Wolf
Johannes Ludescher
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE501154T1 publication Critical patent/ATE501154T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03787771T 2002-08-13 2003-08-12 Ein cefdinir-zwischenprodukt ATE501154T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT12232002 2002-08-13
AT15882002 2002-10-18
PCT/EP2003/008944 WO2004016623A1 (en) 2002-08-13 2003-08-12 A cefdinir intermediate

Publications (1)

Publication Number Publication Date
ATE501154T1 true ATE501154T1 (de) 2011-03-15

Family

ID=31888705

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03787771T ATE501154T1 (de) 2002-08-13 2003-08-12 Ein cefdinir-zwischenprodukt

Country Status (8)

Country Link
US (2) US7250508B2 (de)
EP (2) EP1554289B1 (de)
JP (1) JP2006500356A (de)
KR (2) KR20050087776A (de)
AT (1) ATE501154T1 (de)
AU (1) AU2003255424A1 (de)
DE (1) DE60336331D1 (de)
WO (1) WO2004016623A1 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
ATE501154T1 (de) 2002-08-13 2011-03-15 Sandoz Ag Ein cefdinir-zwischenprodukt
ITMI20022724A1 (it) * 2002-12-20 2004-06-21 Antibioticos Spa Sali cristallini del cefdinir.
EP1609793A4 (de) * 2003-03-24 2008-06-25 Sandoz Ag Neuer kristall von 7-¬2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido-3-vinyl-3-cephem-4-carbonsäure(syn-isomer) und verfahren zu dessen herstellung
US20050137182A1 (en) * 2003-06-02 2005-06-23 Ramesh Dandala Novel crystalline form of cefdinir
US7105659B2 (en) * 2003-06-02 2006-09-12 Aurobind - Pharma Ltd. Process for preparing cefdinir
US20040242556A1 (en) * 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
GB0416380D0 (en) * 2004-07-22 2004-08-25 Sandoz Ag Organic compounds
GB0416379D0 (en) * 2004-07-22 2004-08-25 Sandoz Ag Organic compounds
WO2006018807A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Crystalline forms of cefdinir
EP1797037B1 (de) * 2004-09-29 2014-12-17 Bayer HealthCare LLC Verfahren zur herstellung von 4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenyoxy}n-methylpyridin-2-carboxamid
US7839409B2 (en) * 2004-10-18 2010-11-23 Ali Noorbakhsh Acquisition of extended display identification data (EDID) using inter-IC (I2C) protocol
WO2006059753A1 (en) 2004-11-30 2006-06-08 Astellas Pharma Inc. Novel oral pharmaceutical suspension of cefdinir crystal
KR100912214B1 (ko) * 2005-10-31 2009-08-14 테바 파마슈티컬 인더스트리즈 리미티드 세프디니르 세슘 염의 결정형
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
GB0616865D0 (en) * 2006-08-25 2007-03-28 Phoenix Chemicals Ltd Process
KR101058135B1 (ko) 2008-04-04 2011-08-24 대웅바이오 주식회사 세프디니르 합성에 유용한 중간체 및 이를 이용하여세프디니르를 제조하는 방법
CN102153566B (zh) * 2010-02-11 2012-08-22 深圳市立国药物研究有限公司 头孢地尼的制备方法
CN102010427B (zh) * 2010-11-19 2012-09-12 苏州中联化学制药有限公司 一种头孢地尼的制备方法
CN101974020B (zh) * 2010-11-19 2012-09-12 苏州中联化学制药有限公司 一种头孢地尼的合成方法
JP5619657B2 (ja) * 2011-03-22 2014-11-05 株式会社Ｌｉｘｉｌ 機能性アルミ材及びその電解処理方法
CN102643293A (zh) * 2012-03-30 2012-08-22 石药集团中诺药业（石家庄）有限公司 头孢地尼三元复合物及其用于制备头孢地尼的方法
CN106279207A (zh) * 2016-08-15 2017-01-04 苏州中联化学制药有限公司 一种头孢地尼的合成方法
CN107892676B (zh) * 2017-12-21 2019-11-29 山东金城柯瑞化学有限公司 头孢地尼活性硫酯的制备方法
CN112645898A (zh) * 2020-12-26 2021-04-13 山东金城柯瑞化学有限公司 氨基噻唑乙酰肟酸粒径可控的制备方法
CN113214186A (zh) * 2021-05-18 2021-08-06 山东昌邑四方医药化工有限公司 头孢地尼活性酯的精制方法

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5564M (de) 1964-03-14 1968-01-02
US4409214A (en) 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GB8323034D0 (en) 1983-08-26 1983-09-28 Fujisawo Pharmaceutical Co Ltd 7-substituted-3-vinyl-3-cephem compounds
JPS59184186A (ja) * 1983-04-01 1984-10-19 Meiji Seika Kaisha Ltd 新規セフエム化合物
JPS62206199A (ja) 1986-03-07 1987-09-10 大竹　章 避難カプセル
ZA885709B (en) 1987-08-19 1989-04-26 Fujisawa Pharmaceutical Co Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid(syn isomer)
GB8800295D0 (en) * 1988-01-07 1988-02-10 Fujisawa Pharmaceutical Co Process for preparation of 7-(2-amino-thiazol-4-y)-2-hydroxyimino-acetanidol-3-cephem compounds
EP0630380B1 (de) 1992-02-05 2001-09-05 Biochemie Gesellschaft M.B.H. Verfahren zur reinigung eines 3-cephem-4-carboxyl säure derivates
AT403049B (de) 1995-08-14 1997-10-27 Biochemie Gmbh Abreicherung von 7-adca in 3-vinyl-aca
ATE218572T1 (de) * 1995-12-27 2002-06-15 Hanmi Pharmaceutical Co Ltd Verfahren zur herstellung von cefdinir
ATE216887T1 (de) 1996-02-29 2002-05-15 Fujisawa Pharmaceutical Co Beta-lactam-antibiotikum enthaltende tabletten und verfahren zu deren herstellung
AT404251B (de) 1996-08-14 1998-10-27 Biochemie Gmbh Neues kristallines salz von cefixim
AT405283B (de) 1997-04-04 1999-06-25 Biochemie Gmbh Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
PE20000879A1 (es) 1998-04-29 2000-09-23 Dsm Nv METODO PARA CRISTALIZAR UN ANTIBIOTICO ß-LACTAMICO
JP4544692B2 (ja) 2000-04-13 2010-09-15 大塚化学株式会社 ３−ビニル−セフェム化合物の製造方法
CA2430840A1 (en) * 2000-12-04 2002-06-13 Fujisawa Pharmaceutical Co., Ltd. Process for producing anhydride of aminothiazole derivative
US6388070B1 (en) 2001-01-05 2002-05-14 Orchid Chemicals & Pharmaceuticals Ltd. Thioester derivatives of thiazolyl acetic acid and their use in the preparation of cephalosporin compounds
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
AU2002347539A1 (en) 2001-12-13 2003-06-23 Ranbaxy Laboratories Limited Crystalline cefdinir potassium dihydrate
CN1628118A (zh) 2002-04-26 2005-06-15 兰贝克赛实验室有限公司 制备头孢地尼的方法
ITMI20020913A0 (it) 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
ATE501154T1 (de) * 2002-08-13 2011-03-15 Sandoz Ag Ein cefdinir-zwischenprodukt
ITMI20022076A1 (it) 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.
WO2004046154A1 (en) 2002-11-15 2004-06-03 Orchid Chemicals & Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
ITMI20022724A1 (it) 2002-12-20 2004-06-21 Antibioticos Spa Sali cristallini del cefdinir.
WO2004058695A1 (en) 2002-12-26 2004-07-15 Lupin Limited Novel intermediates for synthesis of cephalosporins and process for preparation of such intermediates
EP1609793A4 (de) 2003-03-24 2008-06-25 Sandoz Ag Neuer kristall von 7-¬2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido-3-vinyl-3-cephem-4-carbonsäure(syn-isomer) und verfahren zu dessen herstellung
WO2004104010A1 (en) 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Crystalline form of cefdinir
US7105659B2 (en) * 2003-06-02 2006-09-12 Aurobind - Pharma Ltd. Process for preparing cefdinir
US20040242556A1 (en) 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US20050137182A1 (en) 2003-06-02 2005-06-23 Ramesh Dandala Novel crystalline form of cefdinir
US20050059819A1 (en) 2003-09-12 2005-03-17 Duerst Richard W. Cefdinir pyridine salt
US20050113355A1 (en) 2003-09-12 2005-05-26 Duerst Richard W. Cefdinir pyridine salt
US20050059818A1 (en) 2003-09-12 2005-03-17 Duerst Richard W. Polymorph of a pharmaceutical
US20050131079A1 (en) 2003-12-10 2005-06-16 Pujara Chetan P. Cefdinir oral suspension
US20060142261A1 (en) 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060025399A1 (en) 2004-03-16 2006-02-02 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060287289A1 (en) 2004-03-16 2006-12-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060211676A1 (en) 2004-03-16 2006-09-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142563A1 (en) 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20050209211A1 (en) 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20050215781A1 (en) 2004-03-17 2005-09-29 Orchid Chemicals & Pharmaceuticals Ltd. Novel polymorph of cefdinir
WO2005090360A1 (en) 2004-03-19 2005-09-29 Orchid Chemicals & Pharmaceuticals Limited Novel polymorph of cefdinir
US20060069079A1 (en) 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20060029674A1 (en) 2004-04-09 2006-02-09 Sever Nancy E Stable amorphous Cefdinir
US20050245738A1 (en) 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
WO2005121154A1 (en) * 2004-06-08 2005-12-22 Teva Pharmaceutical Industries Ltd. Process for the preparation of cefdinir
WO2006010978A1 (en) 2004-06-30 2006-02-02 Wockhardt Limited Cefdinir polymorphic forms, and imidazole salt
JP4856795B2 (ja) 2004-07-05 2012-01-18 オーキッド ケミカルズ アンド ファーマシューティカルズ リミテッド セファロスポリン抗生物質の製造における新規な塩
GB0416379D0 (en) * 2004-07-22 2004-08-25 Sandoz Ag Organic compounds
WO2006018807A1 (en) 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Crystalline forms of cefdinir
WO2006035291A1 (en) 2004-09-27 2006-04-06 Ranbaxy Laboratories Limited Crystalline forms of cefdinir potassium
ITMI20042231A1 (it) 2004-11-19 2005-02-19 Antibioticos Spa Cefdinir sale d'ammonio in forma cristallina
WO2006059753A1 (en) 2004-11-30 2006-06-08 Astellas Pharma Inc. Novel oral pharmaceutical suspension of cefdinir crystal
GB2421024A (en) 2004-12-07 2006-06-14 Sandoz Ag Cefdinir crystalline form C
WO2006117794A1 (en) 2005-05-02 2006-11-09 Hetero Drugs Limited A novel crystalline form of cefdinir
US20080287673A1 (en) * 2005-06-15 2008-11-20 Parthasaradhi Reddy Bandk Cefdinir process
WO2007053723A2 (en) * 2005-10-31 2007-05-10 Teva Pharmaceutical Industries Ltd. Process for the preparation of cefdinir

Also Published As

Publication number Publication date
EP1842852A1 (de) 2007-10-10
US7250508B2 (en) 2007-07-31
US7825241B2 (en) 2010-11-02
AU2003255424A1 (en) 2004-03-03
EP1554289B1 (de) 2011-03-09
EP1554289A1 (de) 2005-07-20
US20060025586A1 (en) 2006-02-02
DE60336331D1 (de) 2011-04-21
JP2006500356A (ja) 2006-01-05
KR20050087776A (ko) 2005-08-31
KR20110005727A (ko) 2011-01-18
WO2004016623A1 (en) 2004-02-26
US20080081906A1 (en) 2008-04-03

Similar Documents

Publication Publication Date Title
ATE501154T1 (de) Ein cefdinir-zwischenprodukt
ATA57097A (de) Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
EA200300211A1 (ru) Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств
ATE425170T1 (de) Kristallformen der zoledronsäure und deren natrioumsalze, amorphes natriumzoledronat und verfahren zu deren herstellung
EP2213674A4 (de) Reinigungsverfahren für pemetrexedsalze, natriumsalze und dinatriumsalze
ATE496895T1 (de) Verfahren für die zubereitung von benzazepinverbindungen oder salzen daraus
FR2846964B1 (fr) Procede de fabrication de 1,2-epoxy-3-chloropropane
WO2004035800A3 (en) Intermediate cefdinir salts
EP1671937A4 (de) Verfahren zur herstellung einer nitrilverbindung, carbonsäureverbindung oder carboxylatverbindung
EP1480260A4 (de) Kristallherstellungsverfahren
EP1864970A4 (de) Verfahren zur herstellung einer disulfonylfluoridverbindung
FR2850966B1 (fr) Procede de fabrication de composes dinitriles
NO20054100L (no) Fremgangsmate for fremstilling av syreaddisjonssalter
BR9909898A (pt) Processo para purificação de um derivado de cefalosporina
PL2062881T3 (pl) Sposób wytwarzania N-(difenylometylo)piperazyn
IS7477A (is) Aðferð við framleiðslu sýrusalts af gemifloxasíni
BR0214445B1 (pt) processos para a produção de compostos.
EP1595883A4 (de) Kristall eines zwischenprodukts von carbapenem
EP1650185A4 (de) Verfahren zur herstellung von optisch aktiven beta-hydroxy-alpha-aminocarbonsäurederivaten
ITMI20050871A1 (it) Solvato cristallino di cefuroxima acido
FR2869030B1 (fr) Procede de production d'alpha-alumine particulaire
EP1582513A4 (de) Verfahren zur reduktiven deshalogenierung
PE20030990A1 (es) Cefalosporinas
ITRM20010318A1 (it) Procedimento per la produzione di composti organici perfluorurati mediante florurazione elettrochimica.
GEP20084394B (en) Novel intermediate for the preparation of therapeutically active imidazopyridines

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties